TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics
Gonçalo Mesquita, Aurélien Haustrate, Adriana Mihalache, Benjamin Soret, Clément Cordier, Emilie Desruelles, Erika Duval, Zoltan Pethö, Natalia Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi · 2023
Read TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics by Gonçalo Mesquita, Aurélien Haustrate, Adriana Mihalache, Benjamin Soret, Clément Cordier, Emilie Desruelles, Erika Duval, Zoltan Pethö, Natalia Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10741494.txt.
Description
Mesquita and ten co-authors study the calcium channel TRPV6 in pancreatic cancer aggressiveness and drug resistance, in a study from twenty twenty-three. Pancreatic ductal cancer is lethal with few treatment options. The channel is overexpressed in several cancers and shapes cell behavior. Tissue from forty-six patients is examined across stages and grades.
Channel levels correlate directly with tumor stage and grade. Knocking it down cuts calcium entry, growth, and survival in two cell lines. Drug susceptibility to standard chemotherapies rises after knockdown. Both knockdown and overexpression reduce tumor formation in animals. Cancer aggressiveness seems to need finely tuned channel levels.
Catalog record
| CREATOR | Gonçalo Mesquita, Aurélien Haustrate, Adriana Mihalache, Benjamin Soret, Clément Cordier, Emilie Desruelles, Erika Duval, Zoltan Pethö, Natalia Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |